SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Assessment of neuropsychological function in brain tumor treatment: a comparison of traditional neuropsychological assessment with app-based cognitive screening.

Romero-Garcia, R; Owen, M; McDonald, A; Woodberry, E; Assem, M; Coelho, P; Morris, RC; Price, SJ; Santarius, T; Suckling, J; et al. Romero-Garcia, R; Owen, M; McDonald, A; Woodberry, E; Assem, M; Coelho, P; Morris, RC; Price, SJ; Santarius, T; Suckling, J; Manly, T; Erez, Y; Hart, MG (2022) Assessment of neuropsychological function in brain tumor treatment: a comparison of traditional neuropsychological assessment with app-based cognitive screening. Acta Neurochir (Wien), 164 (8). pp. 2021-20034. ISSN 0942-0940 https://doi.org/10.1007/s00701-022-05162-5
SGUL Authors: Hart, Michael Gavin

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.docx) (Supplementary file 1) Published Version
Available under License Creative Commons Attribution.

Download (5MB)

Abstract

BACKGROUND: Gliomas are typically considered to cause relatively few neurological impairments. However, cognitive difficulties can arise, for example during treatment, with potential detrimental effects on quality of life. Accurate, reproducible, and accessible cognitive assessment is therefore vital in understanding the effects of both tumor and treatments. Our aim is to compare traditional neuropsychological assessment with an app-based cognitive screening tool in patients with glioma before and after surgical resection. Our hypotheses were that cognitive impairments would be apparent, even in a young and high functioning cohort, and that app-based cognitive screening would complement traditional neuropsychological assessment. METHODS: Seventeen patients with diffuse gliomas completed a traditional neuropsychological assessment and an app-based touchscreen tablet assessment pre- and post-operatively. The app assessment was also conducted at 3- and 12-month follow-up. Impairment rates, mean performance, and pre- and post-operative changes were compared using standardized Z-scores. RESULTS: Approximately 2-3 h of traditional assessment indicated an average of 2.88 cognitive impairments per patient, while the 30-min screen indicated 1.18. As might be expected, traditional assessment using multiple items across the difficulty range proved more sensitive than brief screening measures in areas such as memory and attention. However, the capacity of the screening app to capture reaction times enhanced its sensitivity, relative to traditional assessment, in the area of non-verbal function. Where there was overlap between the two assessments, for example digit span tasks, the results were broadly equivalent. CONCLUSIONS: Cognitive impairments were common in this sample and app-based screening complemented traditional neuropsychological assessment. Implications for clinical assessment and follow-up are discussed.

Item Type: Article
Additional Information: © The Author(s) 2022 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Keywords: Cognitive function, Glioma, Neuropsychiatry, Neuropsychology, Neurosurgery, Neurology & Neurosurgery, 1103 Clinical Sciences, 1109 Neurosciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Acta Neurochir (Wien)
ISSN: 0942-0940
Language: eng
Dates:
DateEvent
August 2022Published
1 March 2022Published Online
16 February 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
A25117Cancer Research UKhttp://dx.doi.org/10.13039/501100000289
CDF-2018-11-ST2-003National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
RG86218Brain Tumour Charityhttp://dx.doi.org/10.13039/501100002203
PubMed ID: 35230551
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114195
Publisher's version: https://doi.org/10.1007/s00701-022-05162-5

Actions (login required)

Edit Item Edit Item